Science
Mechanism of Action
Methyl anthranilate reduces melanin content by inhibiting dendrite elongation and melanosome transfer in melanocytes. It also downregulates key melanogenic enzymes like tyrosinase, TRP-1, and TRP-2, a process mediated by suppressing cyclic adenosine monophosphate (cAMP) production, a critical regulator in the upstream pathway of melanogenesis.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 In vitro and ex vivo studies at 10-50 µg/mL demonstrated dose-dependent inhibition of melanin content, dendrite elongation, and melanosome transfer. It also downregulated melanogenic genes (tyrosinase, TRP-1, TRP-2) and decreased cAMP production, suggesting anti-melanogenic potential without significant cytotoxicity (cell viability > 80%).
Transparency
Dusting Analysis
While Methyl Anthranilate exhibits *in vitro* anti-melanogenic properties, its severe safety profile at higher concentrations (e.g., phototoxicity observed at 1-5%) significantly limits its practical use. Any concentration exceeding the SCCS-recommended 0.1% for leave-on products, or its inclusion in products intended for UV exposure, constitutes a critical safety concern and red flag for precision skincare.
The Formula
Formulation
Stability
Methyl anthranilate is sensitive to air and light. While stable under recommended storage conditions, it is combustible. Its photostability in formulations can be enhanced by quenching its triplet states with UV-B filters such as octocrylene (OCR) and ethylhexyl methoxycinnamate (EHMC).
Synergies
- UV-B filters (e.g., octocrylene, ethylhexyl methoxycinnamate) for photostability
Conflicts
- Strong oxidizing agents
- Isocyanates
- Halogenated organics
- Peroxides
- Phenols (acidic)
- Epoxides
- Anhydrides
- Acid halides
- Alkali metals (generates flammable hydrogen)
- Hydrides (generates flammable hydrogen)
Safety
Safety Profile
Methyl anthranilate is explicitly not recommended for use in sunscreen products or other products marketed for exposure to natural or artificial UV light due to its significant phototoxic potential, as evidenced by studies showing reactions at 1% and 5%. It is a secondary amine, which means it may be prone to nitrosation, potentially forming carcinogenic nitrosamines. Animal studies have indicated moderate skin irritation and corneal effects. The Scientific Committee on Consumer Safety (SCCS) identifies phototoxicity as the primary toxicological endpoint of concern, recommending a maximum of 0.1% for leave-on products (referring to Methyl-N-methylanthranilate, a closely related compound with similar concerns).
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite promising *in vitro* anti-melanogenic properties, Methyl Anthranilate carries severe safety concerns, including significant phototoxicity at concentrations required for its effects, potential carcinogenic nitrosamine formation, and moderate irritation, making it an unsuitable ingredient for precision skincare.
Related
Similar Ingredients
Finding similar ingredients…